Fuso Pharmaceutical announced plans to add a powder dialysate production line at its Okayama No. 2 Plant and reorganize and consolidate its domestic production sites. The investment is expected to total approximately ¥14 billion.
Fuso Pharmaceutical announced that it will install a new powder dialysate production line at its Okayama No. 2 Plant. The move will expand its powder dialysate production capacity.
The investment is reported to be approximately ¥14 billion, and the company has outlined a policy of reorganizing and consolidating its domestic production sites.
The article does not provide specific figures for the new line’s completion date or production capacity. Further disclosure in official materials is awaited.